• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NEK8通过重编程天冬酰胺代谢促进胃癌进展。

NEK8 promotes the progression of gastric cancer by reprogramming asparagine metabolism.

作者信息

Wang Mingliang, Yu Kexun, Meng Futao, Wang Huizhen, Li Yongxiang

机构信息

General Surgery Department, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, China.

出版信息

Mol Med. 2025 Jan 6;31(1):3. doi: 10.1186/s10020-024-01062-9.

DOI:10.1186/s10020-024-01062-9
PMID:39762761
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11702068/
Abstract

Several members of the NIMA-related kinase (NEK) family have been implicated in tumor progression; however, the role and underlying mechanisms of NEK8 in gastric cancer (GC) remain unclear. This study revealed a significant upregulation of NEK8 in GC, identifying it as an independent prognostic marker in patients with GC. Consistent with these findings, NEK8 silencing substantially impeded GC aggressiveness both in vitro and in vivo, while its overexpression produced the opposite effect. Gene Ontology enrichment analysis and metabolic profiling indicated that the impact of NEK8 on GC is primarily associated with reprogramming asparagine metabolism and modulating the mTORC1 pathway. Specifically, NEK8 knockdown suppressed asparagine synthesis by downregulating asparagine synthetase (ASNS) expression in GC cells. A strong correlation was observed between NEK8 levels and ASNS expression in human GC cells and tissue samples. Mechanistically, NEK8 directly interacts with ASNS, phosphorylating it at the S349 site, which inhibits its ubiquitination and subsequent degradation. Moreover, substituting the ASNS-S349 site with alanine abrogated the pro-tumorigenic effects of ASNS-WT overexpression. Additionally, asparagine was identified as an activator of the mTORC1 pathway, with reintroducing asparagine after NEK8 silencing restoring mTORC1 activity. Collectively, these findings demonstrate that NEK8-mediated asparagine synthesis and activation of the mTORC1 pathway play a critical role in promoting GC progression.

摘要

NIMA相关激酶(NEK)家族的几个成员与肿瘤进展有关;然而,NEK8在胃癌(GC)中的作用及潜在机制仍不清楚。本研究揭示了NEK8在GC中显著上调,将其确定为GC患者的独立预后标志物。与这些发现一致,NEK8沉默在体外和体内均显著阻碍了GC的侵袭性,而其过表达则产生相反的效果。基因本体富集分析和代谢谱分析表明,NEK8对GC的影响主要与天冬酰胺代谢重编程和调节mTORC1途径有关。具体而言,NEK8敲低通过下调GC细胞中天冬酰胺合成酶(ASNS)的表达来抑制天冬酰胺合成。在人GC细胞和组织样本中观察到NEK8水平与ASNS表达之间存在强相关性。机制上,NEK8直接与ASNS相互作用,在S349位点使其磷酸化,从而抑制其泛素化及随后的降解。此外,用丙氨酸替代ASNS的S349位点可消除ASNS-WT过表达的促肿瘤作用。此外,天冬酰胺被确定为mTORC1途径的激活剂,NEK8沉默后重新引入天冬酰胺可恢复mTORC1活性。总的来说,这些发现表明NEK8介导的天冬酰胺合成和mTORC1途径的激活在促进GC进展中起关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11702068/c3da368ff1b9/10020_2024_1062_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11702068/471a4805d3d9/10020_2024_1062_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11702068/6d52dc815245/10020_2024_1062_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11702068/472d4d0c906e/10020_2024_1062_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11702068/733b9d447d24/10020_2024_1062_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11702068/0b6de7a6f62a/10020_2024_1062_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11702068/ee98acc4b761/10020_2024_1062_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11702068/dfd91dc1896a/10020_2024_1062_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11702068/c3da368ff1b9/10020_2024_1062_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11702068/471a4805d3d9/10020_2024_1062_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11702068/6d52dc815245/10020_2024_1062_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11702068/472d4d0c906e/10020_2024_1062_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11702068/733b9d447d24/10020_2024_1062_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11702068/0b6de7a6f62a/10020_2024_1062_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11702068/ee98acc4b761/10020_2024_1062_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11702068/dfd91dc1896a/10020_2024_1062_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11702068/c3da368ff1b9/10020_2024_1062_Fig8_HTML.jpg

相似文献

1
NEK8 promotes the progression of gastric cancer by reprogramming asparagine metabolism.NEK8通过重编程天冬酰胺代谢促进胃癌进展。
Mol Med. 2025 Jan 6;31(1):3. doi: 10.1186/s10020-024-01062-9.
2
Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR/ASNS axis.靶向 TLK2 通过 mTOR/ASNS 轴重编程氨基酸代谢抑制胃癌的进展。
Cancer Gene Ther. 2023 Nov;30(11):1485-1497. doi: 10.1038/s41417-023-00653-8. Epub 2023 Aug 4.
3
Asparagine Dependency Is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer.天冬酰胺依赖性是 TP53 改变的去势抵抗性前列腺癌的可靶向代谢脆弱性。
Cancer Res. 2024 Sep 16;84(18):3004-3022. doi: 10.1158/0008-5472.CAN-23-2910.
4
Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cells.敲低天冬酰胺合成酶(ASNS)可抑制胃癌细胞的增殖并抑制肿瘤生长。
Scand J Gastroenterol. 2016 Oct;51(10):1220-6. doi: 10.1080/00365521.2016.1190399. Epub 2016 Jun 2.
5
Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells.利用患者来源的肿瘤起始细胞靶向天冬酰胺合成酶进行肿瘤发生。
Cells. 2022 Oct 18;11(20):3273. doi: 10.3390/cells11203273.
6
Asparagine synthetase regulates lung-cancer metastasis by stabilizing the β-catenin complex and modulating mitochondrial response.天冬酰胺合成酶通过稳定β-连环蛋白复合物和调节线粒体反应来调节肺癌转移。
Cell Death Dis. 2022 Jun 23;13(6):566. doi: 10.1038/s41419-022-05015-0.
7
Growth characteristics of HCT116 xenografts lacking asparagine synthetase vary according to sex.缺乏天冬酰胺合成酶的 HCT116 异种移植物的生长特征根据性别而有所不同。
Hum Genomics. 2024 Jun 17;18(1):67. doi: 10.1186/s40246-024-00635-3.
8
Coordination of asparagine uptake and asparagine synthetase expression modulates CD8+ T cell activation.天冬酰胺摄取和天冬酰胺合成酶表达的协调调节 CD8+T 细胞的激活。
JCI Insight. 2021 May 10;6(9):137761. doi: 10.1172/jci.insight.137761.
9
Asparagine synthetase and G-protein coupled estrogen receptor are critical responders to nutrient supply in KRAS mutant colorectal cancer.天冬酰胺合成酶和 G 蛋白偶联雌激素受体是 KRAS 突变结直肠癌对营养供应的关键反应蛋白。
Int J Cancer. 2025 Jan 1;156(1):52-68. doi: 10.1002/ijc.35104. Epub 2024 Jul 22.
10
The edited UPF1 is correlated with elevated asparagine synthetase in pancreatic ductal adenocarcinomas.编辑后的 UPF1 与胰腺导管腺癌中天门冬酰胺合成酶的升高相关。
Mol Biol Rep. 2022 May;49(5):3713-3720. doi: 10.1007/s11033-022-07211-9. Epub 2022 Feb 7.

引用本文的文献

1
Correction: NEK8 promotes the progression of gastric cancer by reprogramming asparagine metabolism.更正:NEK8通过重编程天冬酰胺代谢促进胃癌进展。
Mol Med. 2025 May 10;31(1):182. doi: 10.1186/s10020-025-01234-1.
2
Metabolism of Tryptophan, Glutamine, and Asparagine in Cancer Immunotherapy-Synergism or Mechanism of Resistance?色氨酸、谷氨酰胺和天冬酰胺在癌症免疫治疗中的代谢——协同作用还是耐药机制?
Metabolites. 2025 Feb 21;15(3):144. doi: 10.3390/metabo15030144.

本文引用的文献

1
Aspartate in tumor microenvironment and beyond: Metabolic interactions and therapeutic perspectives.肿瘤微环境中的天冬氨酸:代谢相互作用与治疗视角。
Biochim Biophys Acta Mol Basis Dis. 2024 Dec;1870(8):167451. doi: 10.1016/j.bbadis.2024.167451. Epub 2024 Aug 5.
2
Molecular characterization and clinical relevance of metabolic signature subtypes in gastric cancer.胃癌代谢特征亚型的分子特征及临床相关性。
Cell Rep. 2024 Jul 23;43(7):114424. doi: 10.1016/j.celrep.2024.114424. Epub 2024 Jul 2.
3
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
4
Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer-single institutional experience.替氟尿苷/替匹嘧啶联合雷莫芦单抗对比替氟尿苷/替匹嘧啶单药治疗晚期胃癌患者的疗效和安全性:单机构经验
Gastric Cancer. 2023 Nov;26(6):1030-1039. doi: 10.1007/s10120-023-01427-9. Epub 2023 Sep 4.
5
Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR/ASNS axis.靶向 TLK2 通过 mTOR/ASNS 轴重编程氨基酸代谢抑制胃癌的进展。
Cancer Gene Ther. 2023 Nov;30(11):1485-1497. doi: 10.1038/s41417-023-00653-8. Epub 2023 Aug 4.
6
Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy.免疫细胞中的氨基酸代谢:效应功能的必需调节剂,以及增强癌症免疫治疗的有希望的机会。
J Hematol Oncol. 2023 Jun 5;16(1):59. doi: 10.1186/s13045-023-01453-1.
7
Amino acid metabolism, redox balance and epigenetic regulation in cancer.癌症中的氨基酸代谢、氧化还原平衡和表观遗传调控。
FEBS J. 2024 Feb;291(3):412-429. doi: 10.1111/febs.16803. Epub 2023 May 19.
8
Targeting glutamine metabolism as a therapeutic strategy for cancer.针对谷氨酰胺代谢作为癌症治疗策略。
Exp Mol Med. 2023 Apr;55(4):706-715. doi: 10.1038/s12276-023-00971-9. Epub 2023 Apr 3.
9
The NEK family of serine/threonine kinases as a biomarker for cancer.丝氨酸/苏氨酸激酶的NEK家族作为癌症的生物标志物。
Clin Exp Med. 2023 Feb;23(1):17-30. doi: 10.1007/s10238-021-00782-0. Epub 2022 Jan 17.
10
High ATF4 Expression Is Associated With Poor Prognosis, Amino Acid Metabolism, and Autophagy in Gastric Cancer.高ATF4表达与胃癌的不良预后、氨基酸代谢及自噬相关。
Front Oncol. 2021 Dec 17;11:740120. doi: 10.3389/fonc.2021.740120. eCollection 2021.